ETC
DNLI icon

Exchange Traded Concepts’s Denali Therapeutics DNLI Stock Holding History

Exchange Traded Concepts’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,584
Closed -$71.9K – 1173
2022
Q4 		$71.9K Buy
2,584
+408
+19% +$12.1K ﹤0.01% 802
2022
Q3 		$67K Buy
2,176
+302
+16% +$9.82K ﹤0.01% 794
2022
Q2 		$55K Buy
1,874
+1,382
+281% +$36.2K ﹤0.01% 899
2022
Q1 		$16K Buy
+492
New +$16.9K ﹤0.01% 1055
2021
Q2 		– Sell
-125
Closed -$7K – 1136
2021
Q1 		$7K Sell
125
-380
-75% -$25.4K ﹤0.01% 1007
2020
Q4 		$42K Buy
+505
New +$30.5K ﹤0.01% 756

Other funds holding DNLI

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return